<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>AGACELL</title>
	<atom:link href="https://agacell.com/feed/" rel="self" type="application/rss+xml" />
	<link>https://agacell.com</link>
	<description></description>
	<lastBuildDate>Tue, 12 May 2026 10:30:28 +0000</lastBuildDate>
	<language>es</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://agacell.com/wp-content/uploads/2026/01/cropped-favicon-32x32.png</url>
	<title>AGACELL</title>
	<link>https://agacell.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Is it possible to say goodbye to baldness? Is science redesigning the future of hair health?</title>
		<link>https://agacell.com/is-it-possible-to-say-goodbye-to-baldness-is-science-redesigning-the-future-of-hair-health/</link>
		
		<dc:creator><![CDATA[AGAcell]]></dc:creator>
		<pubDate>Tue, 12 May 2026 10:30:28 +0000</pubDate>
				<category><![CDATA[Articulos]]></category>
		<guid isPermaLink="false">https://agacell.com/?p=871</guid>

					<description><![CDATA[The course “Goodbye to Baldness? Science Responds with the Latest Advances in the Treatment of Androgenetic Alopecia”, taking place at the CV2026, will explore how cutting-edge research is transforming the field — from new pharmacological therapies to innovations in hair regeneration and cell therapy. 📍 Hotel Dorma Victoria📅 June 29, 2026 Register and apply for [&#8230;]]]></description>
		
		
		<enclosure url="https://ideatx.com/wp-content/uploads/2026/05/linkedin-video.mp4" length="6902352" type="video/mp4" />

			</item>
		<item>
		<title>Eduardo López Bran, dermatologist: “We could be looking at a therapy that would allow a person to fully regain their hair if it can be successfully replicated in humans.”</title>
		<link>https://agacell.com/eduardo-lopez-bran-dermatologist-we-could-be-looking-at-a-therapy-that-would-allow-a-person-to-fully-regain-their-hair-if-it-can-be-successfully-replicated-in-humans/</link>
		
		<dc:creator><![CDATA[AGAcell]]></dc:creator>
		<pubDate>Tue, 12 May 2026 09:45:34 +0000</pubDate>
				<category><![CDATA[Medios]]></category>
		<guid isPermaLink="false">https://agacell.com/?p=868</guid>

					<description><![CDATA[The doctor is leading a project that has achieved up to 100% success in mice and could be available within 5 to 7 years to treat alopecia, as he explained on Herrera en COPE. A Spanish study may be close to finding a solution to common baldness. A team led by Eduardo López Bran, Head [&#8230;]]]></description>
		
		
		<enclosure url="https://ideatx.com/wp-content/uploads/2026/04/FbWca5XOKiCg5ZMrEj-xJ.mp3" length="10763613" type="audio/mpeg" />

			</item>
		<item>
		<title>Doctor López Bran, a dermatology expert: “Spain is the country with the most bald people because our good lifestyle plays a role.”</title>
		<link>https://agacell.com/doctor-lopez-bran-a-dermatology-expert-spain-is-the-country-with-the-most-bald-people-because-our-good-lifestyle-plays-a-role/</link>
		
		<dc:creator><![CDATA[AGAcell]]></dc:creator>
		<pubDate>Tue, 12 May 2026 09:43:55 +0000</pubDate>
				<category><![CDATA[Medios]]></category>
		<guid isPermaLink="false">https://agacell.com/?p=865</guid>

					<description><![CDATA[Factors such as genetics, lifestyle, and other environmental influences can cause hair loss to vary significantly from one country to another. Read more: ABC]]></description>
		
		
		
			</item>
		<item>
		<title>AGACell’s Principal Investigator, Dr. López Bran, Participates as a Speaker at the FUE ASIA Congress</title>
		<link>https://agacell.com/interest-in-spanish-researcher-lopez-brans-work-to-put-an-end-to-baldness-reaches-india/</link>
		
		<dc:creator><![CDATA[AGAcell]]></dc:creator>
		<pubDate>Thu, 29 Jan 2026 09:13:03 +0000</pubDate>
				<category><![CDATA[Medios]]></category>
		<category><![CDATA[AGACELL]]></category>
		<guid isPermaLink="false">https://agacell.com/?p=652</guid>

					<description><![CDATA[Interest in the work of Spanish researcher López Bran aimed at putting an end to baldness has reached India. Research into a new therapy based on the use of stem cells to treat the most common type of baldness—caused by genetic factors—has been one of the main highlights of the FUE ASIA congress, held in [&#8230;]]]></description>
		
		
		
			</item>
		<item>
		<title>Hair transplantation: effective and safe, without medication</title>
		<link>https://agacell.com/hair-transplantation-effective-and-safe-without-medication/</link>
		
		<dc:creator><![CDATA[AGAcell]]></dc:creator>
		<pubDate>Wed, 28 Jan 2026 13:29:11 +0000</pubDate>
				<category><![CDATA[Medios]]></category>
		<category><![CDATA[AGACELL]]></category>
		<guid isPermaLink="false">https://agacell.com/?p=658</guid>

					<description><![CDATA[Dr. López Bran, why do these anti-hair loss drugs raise concerns among the population, especially men? “Among the different options dermatologists have to address androgenetic alopecia, oral finasteride 1 mg, topical finasteride, and oral dutasteride 0.5 mg are surrounded by controversy due to the possible appearance of adverse side effects, which can be very serious [&#8230;]]]></description>
		
		
		
			</item>
		<item>
		<title>The end of baldness in Spain? A nurse reveals a study with ‘very promising’ results.</title>
		<link>https://agacell.com/the-end-of-baldness-in-spain-a-nurse-reveals-a-study-with-very-promising-results/</link>
		
		<dc:creator><![CDATA[AGAcell]]></dc:creator>
		<pubDate>Wed, 28 Jan 2026 09:11:54 +0000</pubDate>
				<category><![CDATA[Medios]]></category>
		<category><![CDATA[AGACELL]]></category>
		<guid isPermaLink="false">https://agacell.com/?p=649</guid>

					<description><![CDATA[Baldness, or alopecia, is the excessive loss of hair from the scalp or other parts of the body.&#160;It occurs when the hair follicle shrinks and stops producing hair, or produces thinner hair, and it can be temporary or permanent.&#160;It is very common in men, and in some cases hair transplants are chosen as a way [&#8230;]]]></description>
		
		
		
			</item>
		<item>
		<title>Entrepreneurship in Biotechnology: Leading with a Vision for the Next Decade</title>
		<link>https://agacell.com/entrepreneurship-in-biotechnology-leading-with-a-vision-for-the-next-decade/</link>
		
		<dc:creator><![CDATA[AGAcell]]></dc:creator>
		<pubDate>Mon, 19 Jan 2026 08:11:21 +0000</pubDate>
				<category><![CDATA[Medios]]></category>
		<category><![CDATA[AGACELL]]></category>
		<guid isPermaLink="false">https://agacell.com/?p=263</guid>

					<description><![CDATA[In biotechnology, leading a company means making decisions today whose true impact will only be visible many years from now. It is accepting that the most important return is not always measured in the next quarter, but in the next decade. Innovation in healthcare requires time, investment, and tolerance for failure. In both a BioTech [&#8230;]]]></description>
		
		
		
			</item>
		<item>
		<title>Marisa Berenguer, CEO of Ideeea Therapeutics: “AGAcell is the first proposal to combine allogeneic mesenchymal stem cells from a healthy external donor to treat androgenetic alopecia.”</title>
		<link>https://agacell.com/marisa-berenguer-ceo-of-ideeea-therapeutics-agacell-is-the-first-proposal-to-combine-allogeneic-mesenchymal-stem-cells-from-a-healthy-external-donor-to-treat-androgenetic-alopecia/</link>
		
		<dc:creator><![CDATA[AGAcell]]></dc:creator>
		<pubDate>Mon, 19 Jan 2026 08:09:53 +0000</pubDate>
				<category><![CDATA[Medios]]></category>
		<category><![CDATA[AGACELL]]></category>
		<guid isPermaLink="false">https://agacell.com/?p=260</guid>

					<description><![CDATA[Farmalider was founded in 1986 and, since its inception, has established itself as one of the leading innovators in health projects in Spain through the constant improvement of pharmaceutical products. The company has now decided to invest in biotechnology to expand its reach, and one of its new flagship projects, AGAcell, is being driven by [&#8230;]]]></description>
		
		
		
			</item>
		<item>
		<title>Mesenchymal stem cells and regeneration</title>
		<link>https://agacell.com/mesenchymal-stem-cells-and-regeneration/</link>
		
		<dc:creator><![CDATA[AGAcell]]></dc:creator>
		<pubDate>Mon, 19 Jan 2026 08:09:25 +0000</pubDate>
				<category><![CDATA[Articulos]]></category>
		<category><![CDATA[AGACELL]]></category>
		<guid isPermaLink="false">https://agacell.com/?p=257</guid>

					<description><![CDATA[Mesenchymal stem cells (MSCs) are stromal cells which self-renew and differentiate to mesodermal lineages. In addition, their capacity to enhance tissue restoration has made them become a central focus in regenerative applications. Their main positive effects are based on immunomodulation and paracrine factors involved in tissue homeostasis, angiogenesis, wound healing and antiapoptosis. MSCs secrete anti-inflammatory [&#8230;]]]></description>
		
		
		
			</item>
		<item>
		<title>Ideeea Therapeutics Selected Among the TOP15 Startups Transforming Spanish Biotechnology</title>
		<link>https://agacell.com/ideeea-therapeutics-selected-among-the-top15-startups-transforming-spanish-biotechnology/</link>
		
		<dc:creator><![CDATA[AGAcell]]></dc:creator>
		<pubDate>Mon, 19 Jan 2026 08:08:54 +0000</pubDate>
				<category><![CDATA[Medios]]></category>
		<category><![CDATA[AGACELL]]></category>
		<guid isPermaLink="false">https://agacell.com/?p=254</guid>

					<description><![CDATA[We are pleased to announce that&#160;Ideeea Therapeutics&#160;has been recognized by&#160;Diario El Referente&#160;as one of the&#160;15 startups that are redefining the biotech landscape in Spain. This recognition highlights our contribution to the advancement of&#160;advanced therapies (ATMPs)&#160;through an innovative, rigorous, and patient-centered approach. Leading Innovation in Regenerative Dermatology From Spain, Ideeea Therapeutics researches and develops cutting-edge biotechnological [&#8230;]]]></description>
		
		
		
			</item>
	</channel>
</rss>
